tiprankstipranks
Krystal Biotech, Inc. (KRYS)
NASDAQ:KRYS
US Market
KRYS
Krystal Biotech
RESEARCH TOOLSreports
Want to see KRYS full AI Analyst Report?

Krystal Biotech (KRYS) Stock News & Sentiment

673 Followers
Analyst Reiterates Buy on Krystal Biotech as Vyjuvek Global Launch and Growing Rare-Disease Pipeline Underpin Long-Term Upside
Premium
Ratings
Analyst Reiterates Buy on Krystal Biotech as Vyjuvek Global Launch and Growing Rare-Disease Pipeline Underpin Long-Term Upside
2d ago
KRYS
Krystal Biotech Earnings Call Highlights Profitable Growth
Premium
Company Announcements
Krystal Biotech Earnings Call Highlights Profitable Growth
15d ago
KRYS
KRYS Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
KRYS Earnings this Week: How Will it Perform?
18d ago
KRYS
Krystal Biotech: Valuation Reflects Pipeline Optimism Amid Dosing and Efficacy Risks, Justifying a Hold Rating
Premium
Ratings
Krystal Biotech: Valuation Reflects Pipeline Optimism Amid Dosing and Efficacy Risks, Justifying a Hold Rating
2M ago
KRYS
Buy Rating on Krystal Biotech Driven by Vyjuvek’s Global Momentum and Upside from Enhanced NK and Corneal Abrasion Pipeline
Premium
Ratings
Buy Rating on Krystal Biotech Driven by Vyjuvek’s Global Momentum and Upside from Enhanced NK and Corneal Abrasion Pipeline
3M ago
KRYS
Krystal Biotech: Transitioning to Global Growth as De‑Risked HSV‑1 Gene Therapy Platform Advances Toward Pivotal Stages
Premium
Ratings
Krystal Biotech: Transitioning to Global Growth as De‑Risked HSV‑1 Gene Therapy Platform Advances Toward Pivotal Stages
3M ago
KRYS
Krystal Biotech: Strong Vyjuvek Performance, De‑Risked Gene Therapy Pipeline, and International Expansion Underscore Buy Rating and $318 Target
Premium
Ratings
Krystal Biotech: Strong Vyjuvek Performance, De‑Risked Gene Therapy Pipeline, and International Expansion Underscore Buy Rating and $318 Target
3M ago
KRYS
More KRYS News >

KRYS News on the Web

Analyst Reiterates Buy on Krystal Biotech as Vyjuvek Global Launch and Growing Rare-Disease Pipeline Underpin Long-Term Upside
TipRanks News
Bullish
Krystal Biotech announces UK MHRA approval of Vyjuvek
TipRanks News
Neutral
Analysts Are Bullish on Top Healthcare Stocks: Legend Biotech (LEGN), Krystal Biotech (KRYS)
TipRanks News
Bullish
U.K.’s MHRA approves Krystal’s Vyjuvek for dystrophic epidermolysis bullosa
TipRanks News
Bullish
Analysts Conflicted on These Healthcare Names: RxSight (RXST), Liquidia Technologies (LQDA) and Krystal Biotech (KRYS)
TipRanks News
Bullish
Krystal Biotech price target raised to $300 from $295 at Evercore ISI
TipRanks News
Bullish
Guggenheim Sticks to Their Buy Rating for Krystal Biotech (KRYS)
TipRanks News
Bullish
Krystal Biotech price target raised to $378 from $371 at Citi
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
KRYS
Sector Average
Media Buzz
This Week5 articles
Weekly Average4 articles
News Sentiment
This Week100%
Sector Average76%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KRYS’s Media Buzz Sentiment?
5 articles about KRYS were published this week. In an average week, 4 articles are published.
    What is KRYS’s weekly average amount of articles?
    In an average week, 4 articles about KRYS are published.
      What is KRYS’s News Sentiment?
      100% of articles about KRYS were positive this week, compared to its sector average of 76%.
        Healthcare Stocks that are Trending in the News
        DOCSDoximity
        AVAHAveanna Healthcare Holdings
        GOSSGossamer Bio
        CGENCompugen
        SPISpire Healthcare
        Showing the stocks with the most bullish news sentiment over the past week